KARYOPHARM THERAPEUTICS INC (KPTI) Institutional Ownership
None of the superinvestors we track currently report KARYOPHARM THERAPEUTICS INC (KPTI) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in KARYOPHARM THERAPEUTICS INC (KPTI), this page will show 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2024 | 1 | $813,312 | 1,202,590 |
| Q3 2024 | 1 | $1,030,368 | 1,241,407 |
| Q2 2024 | 1 | $656,103 | 756,227 |
| Q1 2024 | 1 | $1,369 | 906,800 |
| Q4 2023 | 1 | $1,699 | 1,964,377 |
| Q3 2023 | 1 | $979 | 730,400 |
| Q2 2023 | 1 | $1,195 | 667,400 |
| Q1 2023 | 1 | $2,862 | 735,700 |
| Q4 2022 | 1 | $644 | 189,300 |
| Q3 2022 | 1 | $1,683 | 308,300 |
| Q2 2022 | 1 | $2,051 | 454,800 |
| Q1 2022 | 1 | $1,585 | 215,100 |
Related KPTI Institutional Insights:
- KPTI Institutional Ownership & Insiders Activity
- KPTI Institutional Ownership & 13F Activity
- KPTI Top Institutional Shareholders
- KPTI Institutional Buying Activity
- KPTI Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- KPTI Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings